GENSF
Genus plcHealthcare · $2.1B market cap
Verdict
Share price
$28.95
close of Oct 1, 2026
Fair value
$17.97
Sticker Price
Payback Price
$7.19
buy price
GENSF is Overpriced: at $28.95 it trades 61% above its fair value of $17.97. Its buy price (Payback Price) is $7.19, 75% below today's price. Business quality is limited: none of the 5 key numbers clears the 10% bar.
How we valued it
Free Cash Flow Growth. Free cash flow is growing faster than reported earnings, so we project free cash flow 10 years ahead instead.
Business quality
0 of 5 clear the 10% bar. What are the Big Five?
Follow GENSF
Get notified when it reaches its buy price of $7.19. Free.
Create a free accountAbout Genus plc
Genus plc is a global animal genetics company, with operations extending across North America, Latin America, the United Kingdom, broader Europe, the Middle East, Russia, Africa, and Asia. The firm organizes its business into three primary segments: Genus PIC, Genus ABS, and Genus Research and Development. Through its PIC brand, the company supplies breeding pigs and boar semen, enabling the production of swine with…
Biotechnology
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 1, 2026. How the Payback Price works